323.01 USD
▲-6.07+2.94%
盘后 316.57 0.00%
2026-07-31
市值
$35.91B
市盈率
73.34
EPS
4.40
股息率
—
52 周区间
253.95 – 385.22
成交量
385.28K
Beta
0.49
目标价
415.64
52W 低 253.9552W 高 385.22
价格走势
公司简介
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients w...